Tekla Capital Management LLC Clovis Oncology, Inc. Transaction History

Tekla Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$3.93 - $15.35 $148,161 - $578,695	-37,700 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $482,937 - $967,759	-37,700 Reduced 50.0%	37,700 $561,000
Q3 2017 Nov 13, 2017	SELL	$67.17 - $84.81 $5.06 Million - $6.39 Million	-75,400 Reduced 50.0%	75,400 $6.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	150,800	150,800 $14.1 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.